Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hellmich

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
The Lancet. Infectious Diseases|January 20, 2024
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAchim J Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez-Baño, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
JCO Precision Oncology|September 11, 2020
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung CancerSebastian Michels, Carina Heydt, Bianca van Veggel, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
BMC Health Services Research|April 23, 2022
Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in GermanyMichael Kusch, Hildegard Labouvie, Vera Schiewer, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Nature Communications|June 25, 2022
Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in childrenFelix Dewald, Isabelle Suárez, Ronja Johnen, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
The Lancet. Infectious Diseases|January 20, 2024
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAchim J Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez-Baño, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical TrialSebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
JCO Precision Oncology|September 11, 2020
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung CancerSebastian Michels, Carina Heydt, Bianca van Veggel, et al.
The Journal of Clinical Investigation|May 20, 2009
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesionsMartin L Sos, Kathrin Michel, Thomas Zander, et al.
BMC Health Services Research|April 23, 2022
Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in GermanyMichael Kusch, Hildegard Labouvie, Vera Schiewer, et al.
The Journal of Rheumatology|November 17, 2015
Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 PatientsPia Moinzadeh, Gabriela Riemekasten, Elise Siegert, et al.
Nature Communications|June 25, 2022
Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in childrenFelix Dewald, Isabelle Suárez, Ronja Johnen, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 39